Результаты поиска

Palliative care follow-up for cancer patients combining day-hospital visits and telemedicine: What feasibility?

BackgroundDue to the increasing life expectancy of patients with cancer, palliative care services are increasingly solicited to provide follow-up for individuals living at home. The implementation of teleconsultations represents a potential solution to extend access to palliative care follow-up to a larger number of patients. The aim of this study is to demonstrate the a priori acceptance of teleconsultations among all patients admitted to palliative care, as well as the feasibility of their implementation. We therefore initially explored whether a specific patient profile might limit acceptan

Conference report on the 28th annual meeting of the European Musculo-Skeletal Oncology Society, 29 April-1 May 2015, Athens.

The 28th Annual Meeting of the European Musculo-Skeletal Oncology Society was organised in Athens by the local host Professor Papagelopoulos and his team. The main objective of the meeting was to focus on recent advances in the diagnosis and treatment of bone and soft tissue sarcomas. The interdisciplinary nature of the meeting was of great value-surgeons, oncologists, pathologists, radiologists, and basic researchers discussed new strategies in the war on sarcoma. This report will highlight the major findings of this successful meeting.

Identifying High-Cost, High-Risk Patients Using Administrative Databases in Tuscany, Italy.

Objective(1) Assessing the performance of the algorithm in terms of sensitivity and positive predictive value, considering General Practitioners' (GPs) judgement as benchmark, and (2) describing adverse events (hospitalisation, death, and health services' consumption) of complex patients compared to the general population.Data sources(i) Tuscany administrative database containing health data (2013-5); (ii) lists of complex patients indicated by GPs; and (iii) annual health registry of Tuscany.Study designThe present study is a validation study. It compares a list of complex patients extracted

Proceedings of the RAMI Intern Section Meeting.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Связь между причинами прерывания данных о результатах, отчетных по пациентам, и механизмами отсутствия данных.

ЦЕЛЬ: Неприменение (НР) ответов на анкеты пациентов (PRO) может привести к искажению результатов, если не обрабатывается правильно. Рекомендуется собирать причины НР, но связь между причинами НР и механизмами отсутствия данных остается неизученной. Нами было определено исследование этой связи для интермиттирующего НР. МЕТОДЫ: Пациенты с мультиплексной миеломой заполняли проверенные анкеты PRO при включении и на 12 последующих точках наблюдения. НР определялось как несвоевременное завершение последующего опроса в течение семи дней, что приводило к контакту с пациентом, записыванию причины отсу

The impact of mHealth interventions on medication adherence in breast cancer: a systematic review of randomized controlled trials.

BackgroundNon-adherence to medication can reduce therapeutic effectiveness in breast cancer patients, thereby increasing the risk of disease progression or recurrence. This study aimed to systematically review the existing scientific literature on the impact of mHealth interventions on medication adherence among breast cancer patients.MethodsThis systematic review was conducted following PRISMA guidelines and focused on randomised clinical trials published in English. The review evaluated the effectiveness of mHealth interventions in improving medication adherence in breast cancer patients fro

The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges.

Cardiovascular multidisciplinary heart teams (MDHTs) have evolved significantly over the past decade. These teams play a central role in the treatment of a wide array of cardiovascular diseases affecting interventional cardiology, cardiac surgery, interventional imaging, advanced heart failure, adult congenital heart disease, cardio-oncology, and cardio-obstetrics. To meet the specific needs of both patients and heart programs, the composition and function of cardiovascular MDHTs have had to adapt and evolve. Although lessons have been learned from multidisciplinary cancer care, best practices

Для лечения когнитивного упадка при множественном склерозе необходим междисциплинарный подход: да.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

The feasibility of a Bayesian network model to assess the probability of simultaneous symptoms in patients with advanced cancer.

Although patients with advanced cancer often experience multiple symptoms simultaneously, clinicians usually focus on symptoms that are volunteered by patients during regular history-taking. We aimed to evaluate the feasibility of a Bayesian network (BN) model to predict the presence of simultaneous symptoms, based on the presence of other symptoms. Our goal is to help clinicians prioritize which symptoms to assess. Patient-reported severity of 11 symptoms (scale 0-10) was measured using an adapted Edmonton Symptom Assessment Scale (ESAS) in a national cross-sectional survey among advanced can

Nutritional Prehabilitation Intervention in Hematological Patients Undergoing Bone Marrow Transplant: A Systematic Review of the Literature.

BACKGROUND: Nutritional interventions play a critical role in bone marrow transplant (BMT) patients. This review evaluates the effectiveness of nutritional strategies in mitigating post-transplant malnutrition and improving clinical outcomes. METHODS: A systematic review was conducted using PubMed, CINAHL, Cochrane Library, and Embase. The search terms included "bone marrow transplant", "malnutrition", and "preoperative nutritional interventions". The quality of studies and risk of bias were assessed using the JBI framework, while evidence certainty was evaluated with the Oxford OCEBM. RESUL

Совпадение в полном тексте источника
… Advanced practice nursing: Nutrition Nurse Specialist role and function Clin. Nutr. ESPEN 2018 26 72 76 10.1016/j.clnesp.2018.04.011 29908686 52. Holdoway A. Page F. Bauer J. Dervan N. Maier A.B. …

CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil.

IntroductionChimeric antigen receptor T (CAR-T) cell therapy is an emerging treatment option for relapsed/refractory multiple myeloma (RRMM) that is a multi-step process involving various stakeholders. Appropriate education on the practical logistics is therefore paramount to ensure treatment success.MethodsA group of key opinion leaders met to explore the key elements of setting up and running a CAR-T center in Brazil. For each step in the CAR-T cell therapy process, the experts agreed on basic requirements, gave their key recommendations from practical experience, and considered any remainin

First Clinical Nutrition Outpatient Consultation: A Review of Basic Principles in Nutritional Care of Adults with Hematologic Disease.

MethodsA bibliographic survey was carried out between 2020 and 2022 using two databases: PubMed/MEDLINE and Scientific Electronic Library Online (SciELO) and the information source Academic Google, irrespective of language or geography.ResultsIn the first nutrition consultation (FNC), there should be an investigative direction focused on nutritional interventions in the short, medium, and long term. The record in the patient's medical record is relevant for carrying out the consultation, according to the recommendations of the normative councils of medicine and nutrition. The main steps to be

Vaccination in Oncology Patients: Evidence, Clinical Challenges, and Future Directions.

This narrative review provides a comprehensive synthesis of patients with cancer disproportionately affected by vaccine-preventable infectious diseases due to malignancy-related immune dysfunction and treatment-induced immunosuppression. Vaccination represents a cornerstone of supportive care in oncology; however, vaccine uptake remains suboptimal and immune responses are frequently attenuated, particularly in patients with hematological malignancies and those receiving highly immunosuppressive therapies. This review provides a comprehensive synthesis of current evidence on vaccine immunogenic

Рационализация аферез: Инициатива по повышению качества стволовых ячеек в целях повышения эффективности сбора данных.

Для автоматической трансплантации стволовых клеток (ASCT) требуется эффективный сбор периферийных стволовых клеток крови. В Лондонском научно-медицинском центре (ЛЦЗ) пациенты с высокой степенью риска, страдающие миэломой, регулярно записываются на лечение three- дневные аферозные коллекции для достижения более высоких целевых показателей по количеству клеток CD34+, хотя многим не нужны все запланированные дни, что ведет к неэффективности ресурсов. Была реализована инициатива по повышению качества, направленная на сокращение числа ненужных сессий в рамках two мероприятия:1) снижение целевых по

ESICM LIVES 2016: part two : Milan, Italy. 1–5 October 2016

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Deployed national healthcare services in Hajj mass gathering settings: emergency department experience of Makkah Diyanet Hospital during the 2025 Hajj period.

BackgroundClinical and operational data from independent national Hajj health missions are extremely limited. This study aimed to analyze the demographic and clinical characteristics, presentation patterns, and clinical outcomes of patients presenting to the emergency department of the Makkah Diyanet Turkey Hospital during the 2025 Hajj season.MethodsA retrospective, cross-sectional, analytical study was conducted at a hospital serving 84,942 Turkish pilgrims between April and July 2025. Diagnoses were coded using the International Classification of Diseases, 10th Revision (ICD-10). Referral,

Health-related quality of life dynamics: modeling insights from immunotherapy.

BackgroundUnderstanding health-related quality of life (HRQoL) dynamics is essential for assessing and improving treatment experiences; however, clinical and observational studies struggle to capture their full complexity. We use simulation modeling and the case of Chimeric Antigen Receptor T-cell therapy-a type of cancer immunotherapy that can prolong survival, but carries life-threatening risks-to study HRQoL dynamics.MethodsWe developed an exploratory system dynamics model with mathematical equations and parameter values informed by literature and expert insights. We refined its feedback st

The "Palliative Care Quality of Life Instrument (PQLI)" in terminal cancer patients.

BackgroundThis paper describes the development of a new quality of life instrument in advanced cancer patients receiving palliative care.MethodsThe Palliative Care Quality of Life Instrument incorporates six multi-item and one single-item scale. The questionnaire was completed at baseline and one-week after. The final sample consisted of 120 patients.ResultsThe average time required to complete the questionnaire, in both time points, was approximately 8 minutes. All multi-item scales met the minimal standards for reliability (Cronbach's alpha coefficient > or =.70) either before or during pall

Serious illness conversations and quality of end-of-life care in patients with hematological malignancies-a retrospective quality improvement study.

PurposePatients with hematological malignancies frequently receive aggressive, poor-quality end-of-life care. In oncology, serious illness conversations conducted early in the illness trajectory, focusing on patients' goals, values, and priorities, have been associated with improved end-of-life care and decreased symptoms of anxiety and depression. Yet, evidence of such supportive interventions' impact in hematology remains limited. This study explores the association between receiving a serious illness conversation and the quality of end-of-life care and the timing of serious illness conversa

Establishing a successful outpatient CAR T-Cell program with cilta-cel: real-world experience from an expert roundtable.

In less than a decade since their first approval, chimeric antigen receptor T-cell (CAR-T) therapies have moved into earlier lines of therapy, shifting administration from an inpatient to an outpatient setting and increasing patient demand. Several CAR-T outpatient programs have been initiated to meet patient and institution needs, resulting in resource conservation, increased treatment capacity, reduced hospitalization times, and financial advantages. Ciltacabtagene autoleucel (cilta-cel) is uniquely suited for outpatient administration, given its predictably delayed cytokine release syndrome